The Centers for Disease Control and Prevention just rolled back decades-old guidance that newborns should be offered the hepatitis B vaccine at birth. The agency adopted the recommendation of its vaccine advisory panel known as ACIP, which voted on the policy change at a meeting earlier this month.
In this week’s STATus Report, host Alex Hogan recaps the controversial meeting, explains why observers found it highly irregular, and why it was so alarming to medical experts.
